Wuxi Biologics (Cayman) Goodwill

As of the most recent data (December 2025), WXXWY shows a goodwill of $1.5B. That compares with $1.5B in the prior-year period — up 0.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, WXXWY's goodwill is now $1.5B (was $1.5B) — a 0.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Wuxi Biologics (Cayman) is outperforming or lagging.

Tracking WXXWY's goodwill over time shows whether Wuxi Biologics (Cayman) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5B That compares with $1.5B in the prior-year period — up 0.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Wuxi Biologics (Cayman)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $1.5B) with ownership activity and broader fundamentals.

Wuxi Biologics (Cayman)'s goodwill is $1.5B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.